2023
DOI: 10.1055/s-0043-1772743
|View full text |Cite
|
Sign up to set email alerts
|

Hypereosinophilia Syndrome: Myriad Presentation—A Case Report

Mansi Patel,
Divit Shah,
Sujal Patel
et al.

Abstract: Hypereosinophilic syndrome is a myeloproliferative disorder that is distinguished with the presence of eosinophilia, which is an absolute eosinophil level of more than 1500/µL for no less than 6 months, no recognized cause for eosinophilia, and clear organ involvement characteristics. But, in some cases where patients require therapy to decrease eosinophil counts due to severe symptoms, a lower time period of hypereosinophilic is also admissible. In this case series, we have included three cases in which first… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Eosinophilia is a hallmark of HES, and its occurrence in this patient raises questions about the possible interplay between thalassemia-related pathophysiology and eosinophilic disorders [11]. Previous studies have proposed a potential link between thalassemia and eosinophilia, suggesting that chronic hemolysis and inflammation associated with thalassemia may contribute to releasing eosinophils from the bone marrow [12,13].…”
Section: Discussionmentioning
confidence: 90%
“…Eosinophilia is a hallmark of HES, and its occurrence in this patient raises questions about the possible interplay between thalassemia-related pathophysiology and eosinophilic disorders [11]. Previous studies have proposed a potential link between thalassemia and eosinophilia, suggesting that chronic hemolysis and inflammation associated with thalassemia may contribute to releasing eosinophils from the bone marrow [12,13].…”
Section: Discussionmentioning
confidence: 90%
“…Eosinophils, constituting 3%-5% of circulating blood leukocytes, serve diverse functions in maintaining tissue homeostasis [1]. Eosinophilia encompasses both non-hematologic (reactive) and hematologic (clonal) disorders, potentially leading to end-organ damage [2]. Thrombosis represents a severe complication of HE, with approximately one-quarter of HES patients experiencing thromboembolic events, resulting in 5%-10% mortality [3].…”
Section: Discussionmentioning
confidence: 99%
“…Idiopathic HES is a systemic disease characterized by persistent HE which results in multiple organ damage. It is diagnosed by the presence of HE (AEC ≥1,500/mL for more than a month), involvement of two or more organs, and the exclusion of secondary causes of eosinophilia such as malignancy, parasitic infection, and drug reaction [9].…”
Section: Discussionmentioning
confidence: 99%